Trial Profile
Risedronate for Treatment of Sublesional Osteoporosis After Spinal Cord Injury.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 25 Apr 2011
Price :
$35
*
At a glance
- Drugs Risedronic acid (Primary)
- Indications Metabolic bone diseases; Osteoporosis
- Focus Therapeutic Use
- 23 Oct 2010 New trial record